Bernie Sanders, Ozempic and Wegovy
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 per month for the same drug.
Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy
Sen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy. The Vermont senator, an independent who has long called out drug manufacturers for their costly products, is launching an investigation into the “outrageously high prices” Novo Nordisk charges for the drugs.
Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an investigation Wednesday into the “outrageously high prices” of Novo Nordisk’s
Sanders Launches Senate Investigation into Sky-High Ozempic and Wegovy Drug Prices
Senator Bernie Sanders launched a Senate investigation into the "outrageously high prices" of diabetes and weight loss drugs Ozempic and Wegovy made by Novo Nordisk. Sanders asked Novo Nordisk to
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag
Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications. On Wednesday, Sanders’ office announced that the senator is launching an investigation into Novo Nordisk over the “astronomically high” list prices of their drugs Wegovy and Ozempic.
Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, Wegovy
Sen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy. The Vermont senator, an independent who has long called out drug manufacturers for their costly products, is launching an investigation into the "outrageously ...
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
Negelle Morris, Novo Nordisk's senior vice president and head of U.S. cardiometabolic sales, spoke exclusively with ABC News.
Blockbuster weight-loss drug Wegovy's sales just doubled — and could heat up even more with a price cut
Sales of Wegovy more than doubled in the first quarter year on year to $1.3 billion.
Bernie Sanders slams pharma giant for ‘outrageously high prices’ of Ozempic and Wegovy — says it could ‘bankrupt … our entire health care system’
Bernie Sanders has launched a probe into the “outrageously high prices” that drug giant Novo Nordisk charges for Ozempic and ...